ID
32378
Description
This ODM file contains the form for documentation of any concomitant medication. To be assessed at screening and re-assessed at every visit. Study ID: 103880 Clinical Study ID: ARI103880 Study Title: An open label, single dose, randomized, three period crossover study to investigate the relative bioavailability of 0.5 mg of dutasteride from soft gelatin capsules (reference) vs. soft gelatin capsules containing two investigational formulations in healthy male volunteers. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: dutasteride Trade Name: Duagen,Zytefor,Avolve,Avodart,Avidart,Zyfetor; Zytefor,Zyfetor,Duagen,Avolve,Avodart,Avidart Study Indication: Prostatic Hyperplasia
Mots-clés
Versions (2)
- 28/10/2018 28/10/2018 -
- 28/10/2018 28/10/2018 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
28 octobre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Dutasteride Relative Bioavailability Soft Gelatine Capsules ID 103880
Concomitant Medication
- StudyEvent: ODM
Description
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Description
MONITOR DATA VALIDATION CHECKS • Check that either ’Yes’ or ’No’ box at the top of the page has been completed. If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
Type de données
text
Alias
- UMLS CUI [1]
- C2347852
Description
List of Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Description
MONITOR DATA VALIDATION CHECKS Ensure that the spelling of the Drug Name(s) is correct (use of Trade Names is preferred).
Type de données
text
Alias
- UMLS CUI [1]
- C2360065
Description
Unit Dose of Medication
Type de données
float
Alias
- UMLS CUI [1]
- C2826646
Description
INVESTIGATOR INSTRUCTIONS UNITS Abbreviation Label TAB = Tablet MCL = Microlitre ML = Millilitre L = Litre MCG = Microgram MG = Milligram G = Gram
Type de données
text
Alias
- UMLS CUI [1]
- C1519795
Description
INVESTIGATOR INSTRUCTIONS FREQUENCY Abbreviation Label OD/QD = 1 x Daily BID = 2 x Daily TID = 3 x Daily QID = 4 x Daily PRN = As required
Type de données
text
Alias
- UMLS CUI [1]
- C3476109
Description
INVESTIGATOR INSTRUCTIONS ROUTE Abbreviation Label IM = Intramuscular IH = Inhalation IV = Intravenous NS = Nasal TP = Topical PO = Oral VG = Vaginal
Type de données
text
Alias
- UMLS CUI [1]
- C0013153
Description
Reason for Medication
Type de données
text
Alias
- UMLS CUI [1]
- C2826696
Description
INVESTIGATOR INSTRUCTIONS • Record unknown months as UNK. MONITOR DATA VALIDATION CHECKS • Check that either medication start date is completed or ’Taken Prior to Study?’ is ’Yes’. • It is acceptable for start date to be missing if ’Taken Prior to Study?’ is ’Yes’. • It is acceptable if ’Taken Prior to Study?’ is ’Yes’ and a start date is present, as long as the start date is prior to the date of the subject’s initial visit.
Type de données
partialDate
Alias
- UMLS CUI [1]
- C2826734
Description
Taken Prior to Study?
Type de données
text
Alias
- UMLS CUI [1]
- C2826667
Description
MONITOR DATA VALIDATION CHECKS • Check that either medication stop date is completed or ’Ongoing Medication?’ is ’Yes’. • It is acceptable for stop date to be missing if ’Ongoing Medication?’ is ’Yes’.
Type de données
partialDate
Alias
- UMLS CUI [1]
- C2826744
Description
Ongoing Medication
Type de données
text
Alias
- UMLS CUI [1]
- C2826666
Similar models
Concomitant Medication
- StudyEvent: ODM